We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleClinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells.AuthorsRech AJ; Vonderheide RHPublicationAnnals of the New York Academy of Sciences, 2009, Vol 1174, p99ISSN1749-6632Publication typearticleDOI10.1111/j.1749-6632.2009.04939.x